As of Thursday, Quoin Pharmaceuticals Ltd.’s (NASDAQ:QNRX) stock closed at $0.47, down from $0.48 the previous day. While Quoin Pharmaceuticals Ltd. has underperformed by -2.72%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, QNRX fell by -97.16%, with highs and lows ranging from $28.11 to $0.43, whereas the simple moving average fell by -82.77% in the last 200 days.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Analysis of Quoin Pharmaceuticals Ltd. (QNRX)
One of the most important indicators of Quoin Pharmaceuticals Ltd.’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -298.10% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 3.80, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
For any stock, average volume can also provide valuable insight into volatility, and QNRX is recording 702.72K average volume. On a monthly basis, the volatility of the stock is set at 9.16%, whereas on a weekly basis, it is put at 6.62%, with a loss of -5.10% over the past seven days. Furthermore, long-term investors anticipate a median target price of $8.00, showing growth from the present price of $0.47, which can serve as yet another indication of whether QNRX is worth investing in or should be passed over.
How Do You Analyze Quoin Pharmaceuticals Ltd. Shares?
Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 7.19%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 10.10% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
Are institutional investors increasing their holdings in QNRX shares?
The recent increase in stakes in QNRX appears to be a result of several institutional investors and hedge funds increasing their positions. G1 Execution Services LLC’s position in QNRX has increased by 42.58% in the first quarter. The company now owns 21,909 shares of the stock, with a value of $12488.0, following the purchase of 6,543 additional shares during the last quarter. Citadel Securities LLC made another decreased to its shares in QNRX during the first quarter, downing its stake by -39.50%.
QNRX shares are owned by institutional investors to the tune of 10.10% at present.
